Programme
1st Day:
11:00 - 12:00 12:00 - 12:1512:15 - 13:25
Chairs: 12:15
Keynote
12:45
13:05
Friday, 23rd September 2016
Registration & Coffee WelcomeJosef Glößl - Vice Rector for Research and International Research Collaboration, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria
N.N. - to be announced
Tissue and Organ Replacement
Michael B. Fischer, Dirk Strunk Rainer Marksteiner - Innovacell Biotechnologie AG, Innsbruck, Austria:
“Myoblasts in Clinical Trials - What Lessons Did We Learn About the Future of Cell Therapies?” Michael Cross - University Hospital Leipzig, Germany:
“MSC for GvHD: Multicentre Trials and Tribulations” Hannes Klump - University Hospital Essen, Germany:
“From Pluripotent to Hematopoietic Stem Cells – HOX Proteins Pave the Way”
13:25 - 14:15
Chair:
Chair:
Coffee, Cake & Companies
Iris Ribitsch
Iris Ribitsch
14:15 - 15:30
Chairs: 14:15
Keynote
14:45
15:00
15:15
Chairs: 14:15
Keynote
14:45
15:00
15:15
Musculoskeletal Research
Florien Jenner, Heinz Redl Mari Dezawa - Tohoku University Graduate School of Medicine, Sendai, Japan:
“Unique Newly Discovered Muse Cells May Lead to the Paradigm Shift of Stem Cell Therapy” Johannes Grillari - University of Natural Resources and Life Sciences (BOKU), Vienna, Austria:
“From Cellular Senescence to Circulating miRNA as Biomarkers in Bone Diseases” Iris Ribitsch - VetmedUni Vienna, Austria:
“Repair Processes at the Protein Level - an Exploratory Whole-Proteome Profiling Approach to Follow up Tendon and Cartilage Healing” Sylvia Nürnberger - LBI Trauma & Medical University Vienna, Austria:
“Scaffold Concepts for Cartilage Regeneration”
Florien Jenner, Heinz Redl Mari Dezawa - Tohoku University Graduate School of Medicine, Sendai, Japan:
“Unique Newly Discovered Muse Cells May Lead to the Paradigm Shift of Stem Cell Therapy” Johannes Grillari - University of Natural Resources and Life Sciences (BOKU), Vienna, Austria:
“From Cellular Senescence to Circulating miRNA as Biomarkers in Bone Diseases” Iris Ribitsch - VetmedUni Vienna, Austria:
“Repair Processes at the Protein Level - an Exploratory Whole-Proteome Profiling Approach to Follow up Tendon and Cartilage Healing” Sylvia Nürnberger - LBI Trauma & Medical University Vienna, Austria:
“Scaffold Concepts for Cartilage Regeneration”
15:30 - 17:00
Chair:
Chair:
Coffee & Posters I (P01 - P12)
Renate Kunert
Renate Kunert
17:00 - 18:40
Chairs: 17:00
17:20
17:40
18:00
18:20
Chairs: 17:00
17:20
17:40
18:00
18:20
Framework Issues
Michael Comer, Hermann Katinger Hendrik Jan Ankersmit - Medical University of Vienna, Austria:
“Regulatory Affairs in Regenerative Medicine: the Perspective of a Drug Developer in Regenerative Medicine”
Peter Kampits - Danube University Krems, Austria:
“Transition of Stem Cells to the Clinic - Ethical Issues”
Martin Brunner - Medical University of Vienna, Austria:
“Clinical Studies with ATMPs - Practical Issues” Ilona Reischl - AGES, Vienna, Austria:
“An Update on European Regulatory Activity and Experience” Giancarlo Forte - FNUSA-ICRC/ St. Anne's University Hospital, Brno, Czech Republic:
“Investigating the Role of Mechanosensors in Cell Function and in Cardiac Diseases”
Michael Comer, Hermann Katinger Hendrik Jan Ankersmit - Medical University of Vienna, Austria:
“Regulatory Affairs in Regenerative Medicine: the Perspective of a Drug Developer in Regenerative Medicine”
Peter Kampits - Danube University Krems, Austria:
“Transition of Stem Cells to the Clinic - Ethical Issues”
Martin Brunner - Medical University of Vienna, Austria:
“Clinical Studies with ATMPs - Practical Issues” Ilona Reischl - AGES, Vienna, Austria:
“An Update on European Regulatory Activity and Experience” Giancarlo Forte - FNUSA-ICRC/ St. Anne's University Hospital, Brno, Czech Republic:
“Investigating the Role of Mechanosensors in Cell Function and in Cardiac Diseases”
19:00
Dinner
Barbecue at the BOKU Campus
Barbecue at the BOKU Campus
Programme
2nd Day:
09:00 - 10:30Chairs:
09:00
Keynote
09:45
Keynote
Saturday, 24th September 2016
Cancer and ImmunotherapyThomas Felzmann, Hannes Stockinger
Stanley R. Riddell - University of Washington & Fred Hutchinson Cancer Research Center, Washington, USA:
“Chimeric Antigen Receptor T Cells – Killing Cancer by Design” Ulrich Jäger - Medical University of Vienna, Austria:
“CAR T-Cells: Clinical Application - Getting Started”
10:30 - 11:15
Chair:
Chair:
Coffee & Posters II (P13 - P18)
Renate Kunert
Renate Kunert
11:15 - 13:00
Chair: 11:15
Keynote
12:00
Keynote
12:45
Chair: 11:15
Keynote
12:00
Keynote
12:45
Cardiovascular Research
Johann Wojta Georg Weitzer - Medical University of Vienna, Austria:
“Molecular Basis for the Temporary Activation of Endogenous Cardiac Stem Cells in the Diseased Heart” Wolfram Zimmermann - University Medical Center Göttingen, Germany:
“Translation of Tissue Engineered Heart Repair” Bernhard Haubner - Medical University of Innsbruck, Austria:
“Plasticity of Neonatal Hearts”
Johann Wojta Georg Weitzer - Medical University of Vienna, Austria:
“Molecular Basis for the Temporary Activation of Endogenous Cardiac Stem Cells in the Diseased Heart” Wolfram Zimmermann - University Medical Center Göttingen, Germany:
“Translation of Tissue Engineered Heart Repair” Bernhard Haubner - Medical University of Innsbruck, Austria:
“Plasticity of Neonatal Hearts”
13:00 - 14:00
Chair:
Chair:
Lunch & Posters III (P19 - P23)
Renate Kunert
Renate Kunert
14:00 - 15:20
Chairs:
14:00
Keynote
14:20
14:40
15:00
Chairs:
14:00
Keynote
14:20
14:40
15:00
Clinical Trials with ATMPs
Beatrix Reinprecht, Ilona Reischl
Florian Göbel - Novartis Pharma GmbH, Vienna, Austria:
“How to Implement Innovation: Clinical Trials of CAR T-Cell Therapies in Austria” Dirk Strunk - Paracelsus Medical University Salzburg, Austria:
“Lost in Translation: Which Stem Cells Can Be Used for What Application?” René Geyeregger - St. Anna Childrens Cancer Research Institute, Vienna, Austria:
“The Challenging Way from Compassionate Use to Approved ATMP Study” Elisabeth Mayr - EB-House, Salzburg, Austria:
“Ex Vivo Gene/Cell Therapy: From Named Patient Project to
Phase I/II Clinical Trial”
Beatrix Reinprecht, Ilona Reischl
Florian Göbel - Novartis Pharma GmbH, Vienna, Austria:
“How to Implement Innovation: Clinical Trials of CAR T-Cell Therapies in Austria” Dirk Strunk - Paracelsus Medical University Salzburg, Austria:
“Lost in Translation: Which Stem Cells Can Be Used for What Application?” René Geyeregger - St. Anna Childrens Cancer Research Institute, Vienna, Austria:
“The Challenging Way from Compassionate Use to Approved ATMP Study” Elisabeth Mayr - EB-House, Salzburg, Austria:
“Ex Vivo Gene/Cell Therapy: From Named Patient Project to
Phase I/II Clinical Trial”
15:20 - End
Concluding Remarks & Discussion
Michael Comer - Chairman PACT
Michael Comer - Chairman PACT